Pharmaceutical and Biotech Market Entrance Strategies: Pricing,Reimbursement and Paralle Trade Pharmaceutical and Biotech Market Entrance Strategies examines the key issues that need to be addressed ...more

Market Study March 2006

Bio-Device Licensing: Strategies for Success Bio-Device Licensing: Strategies for Success market research report provides a detail review of the ...more

Market Study December 2006

A Practical Guide to Biopharmaceutical Manufacturing A Practical Guide to Biopharmaceutical Manufacturing market research report provides a detail review of ...more

Market Study December 2006

Stem Cell Therapies and Regenerative Medicine: Current Applications and Future Possibilities The worldwide market for stem cell, cytokine and growth factor therapies is estimated at $12. ...more

Market Study December 2005

The Biotechnology Market Outlook: Growth opportunities and effective strategies for licensing and collaborations (market briefing) This is currently the strongest growth sector in the pharmaceutical market. ...more

Management Report November 2005

The Biotechnology Market Outlook: Growth opportunities and effective strategies for licensing and collaborations (market briefing) In 1982 the US Food and Drug Administration (FDA) approved the first biotech drug, human insulin, which ...more

Management Report November 2005

Major Milestones: Female Sexual Dysfunction Female sexual dysfunction affects an estimated 84 million women across the seven major pharmaceutical ...more

Market Study August 2005

PharmaVitae 2005: Almirall Global and US Analysis This analysis examines the market position and future outlook for Almirall. ...more

Market Study August 2005

PharmaVitae 2005: Almirall Global Analysis This company analysis examines Almirall's market position and future outlook. ...more

Market Study August 2005

Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns? Tysabri was voluntarily withdrawn from the multiple sclerosis market in February 2005 following two cases ...more

Market Study August 2005

PharmaVitae 2005: Altana Global and US Analysis This company analysis examines Altana's market position and future outlook. ...more

Market Study August 2005

PharmaVitae 2005: Altana Global Analysis This company analysis examines Altana's market position and future outlook. ...more

Market Study August 2005

Commercial Insight: Antibacterials - Pharma Strikes Antibac Rapid uptake of products focused on drug-resistant infections, such as Pfizer's Zyvox (linezolid), has ...more

Management Report August 2005

Bioinformatics Business: Technical Status and Market Prospects The worldwide value of bioinformatics is expected to increase from $1.02 billion in 2002 to $3. ...more

Management Report August 2005

Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles Coronary heart disease is the most common cause of death in Europe and the US, at a rate of one in five. ...more

Management Report July 2005

Biotech And Pharmaceutical Spinouts: Maximize your assets' potential in a context of increasing earning pressures Biotechnology and pharmaceutical companies are increasing their focus on their intellectual property and ...more

Management Report July 2005